Navigating the landscape for this new medication and the GLP-1 receptor agonist in the UK can be difficult. Currently, availability through the National Health Service is limited , meaning many people are exploring private avenues to acquire these innovative medications. Acquiring these drugs requires careful consideration of licensed pharmacies an